Efficacy and safety of direct-acting antiviral therapy in previous hard-to-treat patients with recurrent hepatitis C virus infection after liver transplantation: a real-world cohort

Sebastian Bernuth1 First Department of Internal Medicine, Transplant Hepatology

Daniel Grimm1 First Department of Internal Medicine, Transplant Hepatology

Johanna Vollmar1 First Department of Internal Medicine, Transplant Hepatology

Felix Darstein1 First Department of Internal Medicine, Transplant Hepatology

Jens Mittler2 General-, Abdominal- and Transplant-Surgery, University Medical Center, Johannes Gutenberg University, Mainz, Germany

Michael Heise2 General-, Abdominal- and Transplant-Surgery, University Medical Center, Johannes Gutenberg University, Mainz, Germany

Maria Hoppe-Lotichius2 General-, Abdominal- and Transplant-Surgery, University Medical Center, Johannes Gutenberg University, Mainz, Germany

Peter R Galle1 First Department of Internal Medicine, Transplant Hepatology

Hauke Lang2 General-, Abdominal- and Transplant-Surgery, University Medical Center, Johannes Gutenberg University, Mainz, Germany

Tim Zimmermann1 First Department of Internal Medicine, Transplant HepatologyCorrespondence[email protected]

Articles from other publishers (9)